BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25447362)

  • 1. [Obtaining of uterine vacuity in pregnancy loss].
    Beucher G; Dolley P; Stewart Z; Lavoué V; Deffieux X; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Dec; 43(10):794-811. PubMed ID: 25447362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fetal death beyond 14 weeks of gestation: induction of labor and obtaining of uterine vacuity].
    Beucher G; Dolley P; Stewart Z; Carles G; Grossetti E; Dreyfus M
    Gynecol Obstet Fertil; 2015 Jan; 43(1):56-65. PubMed ID: 25511016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First trimester miscarriages: benefits and harms of different management options].
    Beucher G; Dolley P; Stewart Z; Carles G; Dreyfus M
    Gynecol Obstet Fertil; 2014 Sep; 42(9):608-21. PubMed ID: 25153436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical induced abortion].
    Bettahar K; Pinton A; Boisramé T; Cavillon V; Wylomanski S; Nisand I; Hassoun D
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1490-1514. PubMed ID: 27818118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induced abortion: Guidelines for clinical practice - Text of the Guidelines (short text)].
    Vayssière C; Gaudineau A; Attali L; Bettahar K; Eyraud S; Faucher P; Fournet P; Hassoun D; Hatchuel M; Jamin C; Letombe B; Linet T; Msika Razon M; Ohanessian A; Segain H; Vigoureux S; Winer N; Wylomanski S; Agostini A
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1596-1603. PubMed ID: 27818117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
    Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of first trimester miscarriages].
    Beucher G; Beillat T; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1):5-21. PubMed ID: 12592177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.
    Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H
    Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français.
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy loss: French clinical practice guidelines.
    Huchon C; Deffieux X; Beucher G; Capmas P; Carcopino X; Costedoat-Chalumeau N; Delabaere A; Gallot V; Iraola E; Lavoue V; Legendre G; Lejeune-Saada V; Leveque J; Nedellec S; Nizard J; Quibel T; Subtil D; Vialard F; Lemery D;
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():18-26. PubMed ID: 27039249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial.
    Kong GW; Lok IH; Yiu AK; Hui AS; Lai BP; Chung TK
    Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):170-7. PubMed ID: 23488984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
    Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
    Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage.
    Ngai SW; Chan YM; Tang OS; Ho PC
    Hum Reprod; 2001 Jul; 16(7):1493-6. PubMed ID: 11425836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.